Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG27458

C9orf85 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The C9orf85 Knockout HAP1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout pool targeting the uncharacterized gene C9orf85 in human near-haploid HAP1 cells. The haploid background simplifies gene disruption, enabling efficient functional studies of this protein, which is hypothesized to participate in ciliary structure or intraflagellar transport. These cells are suited for ciliogenesis assays, immunocytochemistry for ciliary markers, motility tests, RNA-seq, and functional genomics studies to explore potential roles in ciliopathies. The polyclonal format facilitates rapid phenotypic screening without clonal isolation. For more details, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    C9orf85

    Gene Identifier

    NCBI Gene ID 138241

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The C9orf85 Knockout HAP1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population designed for functional interrogation of the C9orf85 gene. This product is generated by CRISPR/Cas9-mediated gene disruption in the HAP1 human near-haploid cell line, yielding a heterogeneous pool of cells carrying loss-of-function mutations in the target locus. The polyclonal format provides a robust and efficient model system for studying gene function without the need for single-cell cloning, facilitating rapid phenotype screening in a physiologically relevant cellular context.

The host cell line, HAP1, is a human fibroblastoid cell line derived from the male chronic myeloid leukemia KBM-7 line. HAP1 cells exhibit a near-haploid karyotype, which greatly simplifies gene editing by requiring disruption of only a single allele. This characteristic, combined with their adherent growth and stable genome, makes them an ideal platform for generating knockout models, particularly for genes with unknown or poorly characterized functions. The haploid nature reduces genetic complexity and enhances the efficiency of loss-of-function studies.

C9orf85 encodes a protein of currently unknown function; however, domain analyses suggest a potential association with ciliary structures. The protein may be involved in cilium assembly or intraflagellar transport, as it shares features with axonemal and transport components. While its upstream regulators, downstream targets, and interacting partners remain uncharacterized, it is hypothesized to function within the ciliary proteome, possibly interacting with intraflagellar transport proteins or ciliary axonemal proteins. Elucidating its role is critical for understanding ciliary biology and potential ciliopathies.

The HAP1 knockout model provides a powerful system to dissect the function of C9orf85 in a clean genetic background. The haploid genome ensures efficient CRISPR/Cas9-mediated disruption, resulting in a pool of cells with targeted gene inactivation. This model allows researchers to bypass the challenges associated with diploid editing and enables direct assessment of phenotypic consequences. Given the gene??s possible involvement in cilium structure, the HAP1 knockout cells are particularly suited for high-content screening of ciliary phenotypes, motility assays, and transcriptomic profiling to uncover its mechanistic role.

Typical applications include ciliogenesis assays to evaluate cilium formation and maintenance, immunocytochemistry using antibodies against ciliary markers such as acetylated tubulin and Arl13b, and cell motility assays to assess flagellar or ciliary function. Additionally, RNA sequencing can be performed to identify transcriptional changes associated with C9orf85 loss. These polyclonal knockout cells are valuable for genetic screens, functional genomics studies, and exploratory research into the molecular basis of ciliopathies. For further details, technical support, or customization options, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)